McCarson K E
Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City 66160-7417, USA.
Neuroscience. 1999;93(1):361-70. doi: 10.1016/s0306-4522(99)00102-5.
The neurokinin-1 receptor and its tachykinin neuropeptide ligand substance P are associated with the mediation of nociception. Substance P released from primary afferent sensory neurons activates neurokinin receptors on both central and peripheral targets that mediate specific aspects of central sensitization and inflammatory function; however, an autoreceptor function for the neurokinin-1 receptor remains highly controversial. Activation of the neurokinin-1 receptor by substance P during chronic nociception increases neurokinin-1 receptor gene expression in the spinal cord. Similarly, neurokinin-3 receptors on peripheral or target tissues or neurons could play an important role in the sensitization of sensory neurons. Therefore, this study (i) mapped the steady-state levels of substance P-encoding preprotachykinin, neurokinin-1 and neurokinin-3 receptor messenger RNAs in central and peripheral tissues including sensory ganglia, and (ii) investigated whether formalin-evoked nociception altered the quantity or location of neurokinin-1 or neurokinin-3 receptor messenger RNAs in the sensory ganglia or inflamed peripheral targets for substance P. Solution hybridization-nuclease protection assays quantified neurokinin receptor messenger RNA levels in central and peripheral tissues from normal and formalin-inflamed rats. High concentrations of the neurokinin-1 receptor were found in whole brain, spinal cord, and peripheral target organs innervated by substance P-containing neurons. Measurable levels of neurokinin-3 receptor messenger RNA were found only in brain, spinal cord and urinary bladder. Results also show that neither neurokinin-1 nor neurokinin-3 receptor messenger RNAs were detectable in primary afferent sensory neurons in the dorsal root ganglia of normal or formalin-inflamed rats. Neurokinin-1 receptor messenger RNA levels were, however, significantly increased in hindpaw tissues inflamed by formalin for 6 h. These results indicate that the plasticity of neurokinin-1 receptor gene expression in non-neuronal peripheral cells could regulate sensitivity to substance P in a manner similar to that in the spinal cord dorsal horn. Altered neurokinin-1 receptor gene expression provides a useful marker of long-term nociceptive activation and may mediate peripheral mechanisms of hyperalgesia and cellular sensitization during inflammation. Importantly, inflammation does not induce a phenotypic change in afferent sensory neurons providing neurokinin receptor targets for the direct sensitization of these neurons by substance P.
神经激肽-1受体及其速激肽神经肽配体P物质与痛觉的介导有关。初级传入感觉神经元释放的P物质激活中枢和外周靶点上的神经激肽受体,这些受体介导中枢敏化和炎症功能的特定方面;然而,神经激肽-1受体的自身受体功能仍存在高度争议。慢性痛觉过程中,P物质激活神经激肽-1受体可增加脊髓中神经激肽-1受体基因的表达。同样,外周或靶组织或神经元上的神经激肽-3受体可能在感觉神经元的敏化中起重要作用。因此,本研究(i)绘制了包括感觉神经节在内的中枢和外周组织中编码P物质的前速激肽原、神经激肽-1和神经激肽-3受体信使RNA的稳态水平,(ii)研究福尔马林诱发的痛觉是否改变了感觉神经节或P物质炎症外周靶点中神经激肽-1或神经激肽-3受体信使RNA的数量或位置。溶液杂交-核酸酶保护分析定量了正常和福尔马林炎症大鼠中枢和外周组织中神经激肽受体信使RNA的水平。在全脑、脊髓以及由含P物质的神经元支配的外周靶器官中发现了高浓度的神经激肽-1受体。仅在脑、脊髓和膀胱中发现了可测量水平的神经激肽-3受体信使RNA。结果还表明,在正常或福尔马林炎症大鼠的背根神经节初级传入感觉神经元中,未检测到神经激肽-1或神经激肽-3受体信使RNA。然而,福尔马林炎症6小时的后爪组织中神经激肽-1受体信使RNA水平显著升高。这些结果表明,非神经元外周细胞中神经激肽-1受体基因表达的可塑性可能以类似于脊髓背角的方式调节对P物质的敏感性。神经激肽-1受体基因表达的改变提供了长期痛觉激活的有用标志物,并可能介导炎症期间痛觉过敏和细胞敏化的外周机制。重要的是,炎症不会诱导传入感觉神经元的表型变化,从而为P物质直接使这些神经元敏化提供神经激肽受体靶点。